Passage Bio

$15.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-2.14%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell Passage Bio and other stocks, options, and ETFs commission-free!

About PASG

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.

CEO
Bruce A. Goldsmith
Employees
74
Headquarters
Philadelphia, Pennsylvania
Founded
2017
Market Cap
881.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
299.01K
High Today
$16.49
Low Today
$15.67
Open Price
$16.35
Volume
689.49K
52 Week High
$38.23
52 Week Low
$12.10

PASG Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

HTGM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure